310 results on '"Oberlin, Odile"'
Search Results
2. Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)
3. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group
4. Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up
5. The right to be forgotten: a change in access to insurance and loans after childhood cancer?
6. Paratesticular rhabdomyosarcoma in children and adolescents—Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies
7. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study
8. Predictive factors of long‐term follow‐up attendance in very long‐term childhood cancer survivors.
9. Educational and occupational outcomes of childhood cancer survivors 30 years after diagnosis: a French cohort study
10. Local control and sequelae in localised Ewing tumours of the spine: A French retrospective study
11. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
12. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study
13. Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma – A report from the Société Française des Cancers et leucémies de l’Enfant et de l’adolescent (SFCE)
14. Local therapy is critical in localised pelvic rhabdomyosarcoma: Experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee
15. Risk adapted chemotherapy for localised Ewing’s sarcoma of bone: The French EW93 study
16. Synovial sarcoma in children and adolescents: A critical reappraisal of staging investigations in relation to the rate of metastatic involvement at diagnosis
17. Moving Forward with Metronomic Chemotherapy: Meeting Report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology
18. Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: Results of a pooled analysis from United States and European groups
19. Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment
20. Association of Radiation Dose to the Eyes With the Risk for Cataract After Nonretinoblastoma Solid Cancers in Childhood
21. Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups
22. Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer
23. Primary Cutaneous and Subcutaneous Ewing Sarcoma
24. Ovarian reserve after treatment with alkylating agents during childhood
25. Testicular function of survivors of childhood cancer: A comparative study between ifosfamide- and cyclophosphamide-based regimens
26. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience
27. Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma
28. Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease
29. Brachytherapy in Children With Rhabdomyosarcomas of the Nasolabial Fold
30. Conservative Approach in Localised Rhabdomyosarcoma of The Bladder and Prostate: Results from International Society of Paediatric Oncology (SIOP) studies: Malignant Mesenchymal Tumour (MMT) 84, 89 and 95
31. Impact of extensive surgery in multidisciplinary approach of pterygopalatine/infratemporal fossa soft tissue sarcoma
32. Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood
33. Late Effects in 164 Patients With Rhabdomyosarcoma of the Bladder/Prostate Region: A Report From the International Workshop
34. Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: earlier but rarely premature
35. Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE)
36. Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality
37. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: Combined results from the Childrenʼs Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee
38. The development of an international childhood cancer hospital register database in 13 African countries. A project of the French African Pediatric Oncology Group (GFAOP).
39. Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma–experience from the European network group on pediatric Hodgkin lymphoma
40. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: A case–control study
41. O.099 TOXICITY OF HIGH-DOSE BUSULFAN-MELPHALAN (BUMEL) CHEMOTHERAPY FOLLOWED BY RADIATION THERAPY (RT) IN EWINGʼS AXIAL TUMOURS: PRELIMINARY RESULTS OF A FRENCH QUALITY CONTROL STUDY
42. O.083 INCIDENCE AND PROGNOSTIC VALUE OF TUMOUR CELLS DETECTED BY REVERSED TRANSCRIPTASE POLYMERASE CHAIN REACTION IN PERIPHERAL BLOOD STEM COLLECTIONS FROM PATIENTS WITH EWING TUMOUR
43. O.054 IMPACT OF HIGH-DOSE BUSULFAN/MELPHALAN IN METASTATIC EWING SARCOMA, A STUDY FROM THE SOCIETE FRANÇAISE DES CANCERS DE LʼENFANT
44. O.052 MULTIVARIATE ANALYSIS BASED RISK GROUPING OF EWING TUMOURS (ET) WITH EXTRA-PULMONARY METASTATIC DISEASE (EPMD). RESULTS FROM THE EURO EWING 99 STUDY
45. Impact of High-Dose Busulfan Plus Melphalan As Consolidation in Metastatic Ewing Tumors: A Study by the Société Française des Cancers de lʼEnfant
46. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial
47. Goitre and iodine deficiency in Afghanistan: a case–control study
48. PHASE II AND PHARMACOKINETIC SFOP STUDY OF HIGH DOSE OF THIOTEPA IN CHILDREN WITH REFRACTORY SOLID TUMOURS: P.F.007
49. DESIGN AND COHORT CHARACTERISTICS OF A FRENCH CHILDHOOD CANCER SURVIVOR STUDY: P.E.014
50. A PROSPECTIVE MULTICENTRE EVALUATION OF INTENSIVE TREATMENT INCLUDING HIGH DOSE CHEMOTHERAPY (HDT) AND PSCR FOR EWING TUMOURS (ET) WITH EXTRA-PULMONARY METASTATIC DISEASE (EPMD).: P.C.005
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.